AU4222785A - Creación de Inventos y Patentes con Inteligencia Artificial

AU4222785A – Propylene glycol – glycerine mixture as an enhancer in transdermal composition
– Google Patents

AU4222785A – Propylene glycol – glycerine mixture as an enhancer in transdermal composition
– Google Patents
Propylene glycol – glycerine mixture as an enhancer in transdermal composition

Info

Publication number
AU4222785A

AU4222785A
AU42227/85A
AU4222785A
AU4222785A
AU 4222785 A
AU4222785 A
AU 4222785A
AU 42227/85 A
AU42227/85 A
AU 42227/85A
AU 4222785 A
AU4222785 A
AU 4222785A
AU 4222785 A
AU4222785 A
AU 4222785A
Authority
AU
Australia
Prior art keywords
enhancer
propylene glycol
transdermal composition
glycerine mixture
glycerine
Prior art date
1984-05-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU42227/85A
Inventor
James Lawrence Gaskill
Robert Peter Giannini
Pramod Purushottam Sarpotdar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wyeth LLC

Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-05-10
Filing date
1985-05-09
Publication date
1985-11-14

1985-05-09
Application filed by American Home Products Corp
filed
Critical
American Home Products Corp

1985-11-14
Publication of AU4222785A
publication
Critical
patent/AU4222785A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/12—Carboxylic acids; Salts or anhydrides thereof

AU42227/85A
1984-05-10
1985-05-09
Propylene glycol – glycerine mixture as an enhancer in transdermal composition

Abandoned

AU4222785A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US60883584A

1984-05-10
1984-05-10

US608835

1984-05-10

Publications (1)

Publication Number
Publication Date

AU4222785A
true

AU4222785A
(en)

1985-11-14

Family
ID=24438225
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU42227/85A
Abandoned

AU4222785A
(en)

1984-05-10
1985-05-09
Propylene glycol – glycerine mixture as an enhancer in transdermal composition

Country Status (6)

Country
Link

EP
(1)

EP0165696A3
(en)

JP
(1)

JPS6117513A
(en)

KR
(1)

KR850008279A
(en)

AU
(1)

AU4222785A
(en)

GB
(1)

GB2158355A
(en)

ZA
(1)

ZA853488B
(en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4756710A
(en)

1985-04-05
1988-07-12
Merck & Co., Inc.
pH-Mediated drug delivery system

US4690683A
(en)

1985-07-02
1987-09-01
Rutgers, The State University Of New Jersey
Transdermal varapamil delivery device

JPH0667825B2
(en)

1985-10-31
1994-08-31
興和株式会社

Water-containing patch for bronchodilation and method for producing the same

JPS62106013A
(en)

1985-10-31
1987-05-16
Kowa Co
Composition for external administration

US4816258A
(en)

1987-02-26
1989-03-28
Alza Corporation
Transdermal contraceptive formulations

US4788062A
(en)

1987-02-26
1988-11-29
Alza Corporation
Transdermal administration of progesterone, estradiol esters, and mixtures thereof

US4788064A
(en)

1987-07-31
1988-11-29
Warner-Lambert Company
Transdermal delivery system

US4906475A
(en)

1988-02-16
1990-03-06
Paco Pharmaceutical Services
Estradiol transdermal delivery system

US5223261A
(en)

1988-02-26
1993-06-29
Riker Laboratories, Inc.
Transdermal estradiol delivery system

US4994267A
(en)

1988-03-04
1991-02-19
Noven Pharmaceuticals, Inc.
Transdermal acrylic multipolymer drug delivery system

US4942158A
(en)

1988-10-13
1990-07-17
Eastman Kodak
Transdermal steroid penetrant compositions and methods utilizing isopropanol and isobutanol

EP0371496A1
(en)

1988-12-01
1990-06-06
Schering Corporation
Compositions for transdermal delivery of estradiol

US5198223A
(en)

1990-10-29
1993-03-30
Alza Corporation
Transdermal formulations, methods and devices

IE913738A1
(en)

1990-10-29
1992-05-22
Alza Corp
Transdermal contraceptive formulations, methods and devices

US5320850A
(en)

1990-10-29
1994-06-14
Alza Corporation
Transdermal delivery of the gestogen ST-1435 and devices therefor

US5518734A
(en)

1991-09-25
1996-05-21
Beta Pharmaceuticals Co.
Transdermal delivery system for estradiol and process for manufacturing said device

US5705185A
(en)

1991-09-25
1998-01-06
Beta Pharmaceuticals Co.
Transdermal delivery of estradiol and process for manufacturing said device

US5558873A
(en)

1994-06-21
1996-09-24
Kimberly-Clark Corporation
Soft tissue containing glycerin and quaternary ammonium compounds

DE4429667C2
(en)

1994-08-20
1996-07-11
Lohmann Therapie Syst Lts

Estradiol TTS with water-binding additives and process for its preparation

US5665426A
(en)

1995-02-06
1997-09-09
Kimberly-Clark Corporation
Soft treated tissue

US5601871A
(en)

1995-02-06
1997-02-11
Krzysik; Duane G.
Soft treated uncreped throughdried tissue

US5885697A
(en)

1996-12-17
1999-03-23
Kimberly-Clark Worldwide, Inc.
Soft treated tissue

GB0019357D0
(en)

2000-08-07
2000-09-27
Melacure Therapeutics Ab
Novel phenyl guanidines

KR100433363B1
(en)

2002-04-15
2004-05-28
주식회사 동구제약
Epidermal hydrogel formulation containing acyclovir

AU2006219729A1
(en)

2005-03-04
2006-09-08
Acure Pharma Ab
Methods and pharmaceutical compositions for the treatment of neurological damage

US8846725B2
(en)

2011-01-24
2014-09-30
Quadex Pharmaceuticals, Llc
Highly penetrating compositions and methods for treating pathogen-induced disordered tissues

CN105833279B
(en)

2016-05-30
2021-06-22
傅远桥
External-use medicine composition for treating various wound surfaces of skin and preparation method thereof

CN112057435A
(en)

2020-08-27
2020-12-11
北京易道归元生物科技研究院
Medical preparation and medicament containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3928609A
(en)

1973-04-05
1975-12-23
Dooner Lab
Non-alcoholic theophylline product

JPS5933211A
(en)

1982-08-20
1984-02-23
Sato Seiyaku Kk
Oleaginous ointment

1985

1985-05-08
ZA
ZA853488A
patent/ZA853488B/en
unknown

1985-05-09
AU
AU42227/85A
patent/AU4222785A/en
not_active
Abandoned

1985-05-09
GB
GB08511806A
patent/GB2158355A/en
not_active
Withdrawn

1985-05-09
EP
EP85303283A
patent/EP0165696A3/en
not_active
Withdrawn

1985-05-09
KR
KR1019850003158A
patent/KR850008279A/en
not_active
Application Discontinuation

1985-05-09
JP
JP60099409A
patent/JPS6117513A/en
active
Pending

Also Published As

Publication number
Publication date

ZA853488B
(en)

1986-12-30

JPS6117513A
(en)

1986-01-25

KR850008279A
(en)

1985-12-16

GB2158355A
(en)

1985-11-13

GB8511806D0
(en)

1985-06-19

EP0165696A3
(en)

1987-05-20

EP0165696A2
(en)

1985-12-27

Información de contacto